The 10-day moving average for CIA crossed bullishly above the 50-day moving average on October 30, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on CIA as a result. In 78 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.
CIA moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +11.02% 3-day Advance, the price is estimated to grow further. Considering data from situations where CIA advanced for three days, in 205 of 262 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CIA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
CIA broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for CIA entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 51 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.889) is normal, around the industry mean (1.352). P/E Ratio (17.957) is within average values for comparable stocks, (20.493). Projected Growth (PEG Ratio) (1.090) is also within normal values, averaging (0.463). CIA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.047). P/S Ratio (0.718) is also within normal values, averaging (1.303).
The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating fairly steady price growth. CIA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 84 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CIA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock worse than average.
The 10-day moving average for CNO crossed bullishly above the 50-day moving average on October 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 73%.
The Momentum Indicator moved above the 0 level on October 13, 2026. You may want to consider a long position or call options on CNO as a result. In 51 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 59%.
The Moving Average Convergence Divergence (MACD) for CNO just turned positive on October 15, 2026. Looking at past instances where CNO's MACD turned positive, the stock continued to rise in 30 of 47 cases over the following month. The odds of a continued upward trend are 64%.
CNO moved above its 50-day moving average on October 27, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +6.02% 3-day Advance, the price is estimated to grow further. Considering data from situations where CNO advanced for three days, in 207 of 329 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
The Aroon Indicator entered an Uptrend today. In 184 of 296 cases where CNO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 62%.
The 10-day RSI Indicator for CNO moved out of overbought territory on November 03, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 41 similar instances where the indicator moved out of overbought territory. In 23 of the 41 cases, the stock moved lower in the following days. This puts the odds of a move lower at 56%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
CNO broke above its upper Bollinger Band on October 30, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Profit vs. Risk Rating rating for this company is 3 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. CNO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 63 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.061) is normal, around the industry mean (1.352). P/E Ratio (19.503) is within average values for comparable stocks, (20.493). Projected Growth (PEG Ratio) (0.210) is also within normal values, averaging (0.463). Dividend Yield (0.012) settles around the average of (0.047) among similar stocks. P/S Ratio (1.156) is also within normal values, averaging (1.303).
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
CIA | CNO | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 35 | 45 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 51 Fair valued | 63 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 3 | |
SMR RATING 1..100 | 100 | 94 | |
PRICE GROWTH RATING 1..100 | 62 | 40 | |
P/E GROWTH RATING 1..100 | 84 | 15 | |
SEASONALITY SCORE 1..100 | 85 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CIA's Valuation (51) in the Life Or Health Insurance industry is in the same range as CNO (63). This means that CIA’s stock grew similarly to CNO’s over the last 12 months.
CNO's Profit vs Risk Rating (3) in the Life Or Health Insurance industry is significantly better than the same rating for CIA (100). This means that CNO’s stock grew significantly faster than CIA’s over the last 12 months.
CNO's SMR Rating (94) in the Life Or Health Insurance industry is in the same range as CIA (100). This means that CNO’s stock grew similarly to CIA’s over the last 12 months.
CNO's Price Growth Rating (40) in the Life Or Health Insurance industry is in the same range as CIA (62). This means that CNO’s stock grew similarly to CIA’s over the last 12 months.
CNO's P/E Growth Rating (15) in the Life Or Health Insurance industry is significantly better than the same rating for CIA (84). This means that CNO’s stock grew significantly faster than CIA’s over the last 12 months.
| CIA | CNO | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 79% | 2 days ago 56% |
| Stochastic ODDS (%) | 2 days ago 71% | 2 days ago 50% |
| Momentum ODDS (%) | 2 days ago 82% | 2 days ago 59% |
| MACD ODDS (%) | N/A | 2 days ago 64% |
| TrendWeek ODDS (%) | 2 days ago 81% | 2 days ago 61% |
| TrendMonth ODDS (%) | 2 days ago 84% | 2 days ago 61% |
| Advances ODDS (%) | 2 days ago 78% | 4 days ago 63% |
| Declines ODDS (%) | 11 days ago 81% | N/A |
| BollingerBands ODDS (%) | 2 days ago 76% | 2 days ago 68% |
| Aroon ODDS (%) | 2 days ago 77% | 2 days ago 62% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CIA’s FA Score shows that 0 FA rating(s) are green while CNO’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CIA’s TA Score shows that 4 TA indicator(s) are bullish while CNO’s TA Score has 6 bullish TA indicator(s).
CIA (@Life/Health Insurance) experienced а +8.68% price change this week, while CNO (@Life/Health Insurance) price change was +6.16% for the same time period.
The average weekly price growth across all stocks in the @Life/Health Insurance industry was -0.38%. For the same industry, the average monthly price growth was -1.32%, and the average quarterly price growth was -4.04%.
CIA is expected to report earnings on Mar 18, 2027.
CNO is expected to report earnings on Feb 09, 2027.
Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.
A.I.dvisor indicates that over the last year, CIA has been loosely correlated with MET. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if CIA jumps, then MET could also see price increases.
A.I.dvisor indicates that over the last year, CNO has been loosely correlated with LNC. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if CNO jumps, then LNC could also see price increases.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| DRN | 10.88 | 0.98 | +9.90% |
| Direxion Daily Real Estate Bull 3X ETF (DRN) | |||
| KRE | 74.13 | 1.25 | +1.72% |
| State Street SPDR S&P Regional Banking ETF (KRE) | |||
| EDGX | 26.51 | 0.38 | +1.45% |
| Global X U.S. 500 Income Edge ETF (EDGX) | |||
| IBMR | 25.17 | 0.03 | +0.14% |
| iShares iBonds Dec 2029 Term Muni Bond ETF (IBMR) | |||
| HFGM | 29.29 | -0.02 | -0.07% |
| Unlimited Hfgm Global Macro ETF | |||